COLUMBIA, S.C., Jan. 7 /PRNewswire-FirstCall/ -- Collexis Holdings Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today that their life science research portal http://www.BiomedExperts.com has surpassed 80,000 registered users. The unique visitor traffic in December has exploded to over 60,000 per day and surpassed 1.4 million unique visitors in December!

(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )

"We are very pleased with the user registration growth of BiomedExperts as well as the accolades that we are receiving from the industry," stated Bill Kirkland, CEO of Collexis Holdings, Inc. "As our user registration base grows along with our page views, BiomedExperts is poised to become the industry standard for life science researchers. We are looking forward to the future releases of BiomedExperts and the launch of new portals across the other scientific disciplines and industries."

Research and advisory firm Outsell, Inc. selected BiomedExperts as one of the top 10 social communities to watch in 2009, in its report "Social Media in STM Part 1: Social Networking" (http://www.outsellinc.com/store/products/792?refid=prcol792). A recent Elsevier study found after only seven months post launch, BiomedExperts was the second most frequently used life science social network behind Nature but ahead of Facebook, MySpace and LinkedIn. Also the launch announcement of BiomedExperts was the #1 headline on the eHealthNews.EU news portal for 2008.

Pre-populated with over 1.8 million Pub-Med-based expert profiles, BiomedExperts allows scientists and researchers to directly connect with and explore their own professional contacts, grow their networks and identify researchers with the expertise needed for future collaborations. Through user-friendly search interfaces, potential research collaborators can share data and collaborate with professionals from more than 1,800 organizations and institutions from 137 countries, totaling more than 21 million connections made through the site.

About Collexis Holdings, Inc.

Collexis Holdings, Inc., a leading developer of semantic search and knowledge discovery software is headquartered in Columbia, South Carolina (USA) with operations in Cincinnati, Ohio and Cologne, Germany. Collexis now offers the world's first pre-populated scientific social network for life science researchers, http://www.biomedexperts.com . Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit http://www.collexis.com .

Forward-Looking Statements

Some of the statements made in this press release may constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward- looking statements. These statements involve risks and uncertainties, including risks and uncertainties associated with BiomedExperts.com. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-KSB for the period ended June 30, 2008. The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.

SOURCE Collexis Holdings Inc.